3 drug(s) with this reaction
55 total reports
Tooth Discolouration has been reported as an adverse reaction across 3 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 55 adverse event reports mention tooth discolouration in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with tooth discolouration, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have tooth discolouration listed in their FDA adverse event reports, sorted by report count:
In addition to tooth discolouration, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
3 drug(s) manufactured by Haleon Us Holdings Llc have tooth discolouration listed in their FDA adverse event reports: STANNOUS FLUORIDE, POTASSIUM NITRATE, SODIUM FLUORIDE, POTASSIUM NITRATE AND SODIUM FLUORIDE.
There are a combined 55 reports of tooth discolouration across 3 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.